Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?

To: flickerful who wrote (367)	12/29/1997 9:38:00 PM
From: 5,17,37,5,101,...	Read Replies (2) \| Respond to of 756

Well I was right about the volume and the move down to 7 1/4, but unfortunately not right about a return to the highs. Ivax is really a darkest-before-dawn and lightest-before-dusk stock -- a real swinger that needs to do some swinging to the upside. Crazy. idleminded speculation: 1) Imagine Ivax's cash flow without a marketing department or upper management; 2) Imagine what a company like Glaxo (that might have a large number of drugs going off-patent) could do with Ivax's cash flow; and voile!=> Frosty is buttering up this turkey for a sale in 6 months. Oh well, didn't Emily Dickinson once say that hope is a dead bird with pretty feathers. :) Better luck tomorrow, Jackson